Neues in der zielgerichteten Therapie und Immuntherapie bei Lungenkrebs
Crossref DOI link: https://doi.org/10.1007/s15033-021-2745-5
Published Online: 2021-09-10
Published Print: 2021-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hammerschmidt, Stefan
Text and Data Mining valid from 2021-09-01
Version of Record valid from 2021-09-01
Article History
First Online: 10 September 2021